No Data
RBC Capital Initiates Avidity Biosciences(RNA.US) With Buy Rating, Announces Target Price $67
Avidity Biosciences Initiated With an Outperform at RBC Capital
Express News | Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Insider Sale: Chief Human Resources Officer of $RNA (RNA) Sells 25,000 Shares
RNA Stock Hits Record High on Entering the Cardiac Disease Space